Cipla recalls 4,800 bottles of anti-HIV tablets from US

As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is 'failed dissolution specifications'.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2BLmzRR
via IFTTT